MicroRNAs in C. elegans Aging: Molecular Insurance for Robustness?
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
The last decade has witnessed a revolution in our appreciation of the extensive regulatory gene expression networks modulated by small untranslated RNAs. microRNAs (miRNAs), ~22 nt RNAs that bind imperfectly to partially homologous sites on target mRNAs to regulate transcript expression, are now known to influence a broad range of biological processes germane to development, homeostatic regulation and disease. It has been proposed that miRNAs ensure biological robustness, and aging has been described as a progressive loss of system and cellular robustness, but relatively little work to date has addressed roles of miRNAs in longevity and healthspan (the period of youthful vigor and disease resistance that precedes debilitating decline in basic functions). The C. elegans model is highly suitable for testing hypotheses regarding miRNA impact on aging biology: the lifespan of the animal is approximately three weeks, there exist a wealth of genetic mutations that alter lifespan through characterized pathways, biomarkers that report strong healthspan have been defined, and many miRNA genes have been identified, expression-profiled, and knocked out. 50/114 C. elegans miRNAs change in abundance during adult life, suggesting significant potential to modulate healthspan and lifespan. Indeed, miRNA lin-4 has been elegantly shown to influence lifespan and healthspan via its lin-14 mRNA target and the insulin signaling pathway. 27 of the C. elegans age-regulated miRNAs have sequence similarity with both fly and human miRNAs. We review current understanding of a field poised to reveal major insights into potentially conserved miRNA-regulated networks that modulate aging.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans
Murphy, C. T., McCarroll, S. A., Bargmann, C. I., Fraser, A., Kamath, R. S., Ahringer, J., Li, H., & Kenyon, C. (2003) · Nature · doi:10.1038/nature01789 · Cited by 2,280
The microRNAs of Caenorhabditis elegans
Lim, L. P., Lau, N. C., Weinstein, E. G., Abdelhakim, A., Yekta, S., Rhoades, M. W., Burge, C. B., & Bartel, D. P. (2003) · Genes & Development · doi:10.1101/gad.1074403 · Cited by 1,259 · cited 2×
“elegans model, with the plethora of molecular and genetic manipulations that can be executed, the comprehensive identification of conserved miRNAs that has been accomplished [32], the wealth of available miRNA deletion mutants [38], records of spatiotemporal expression patterns for many canonical miRNAs [37, 44-47], a…”
BackgroundStochastic and genetic factors influence tissue-specific decline in ageing C. elegans
Herndon, L. A., Schmeissner, P. J., Dudaronek, J. M., Brown, P. A., Listner, K. M., Sakano, Y., Paupard, M. C., Hall, D. H., & Driscoll, M. (2002) · Nature · doi:10.1038/nature01135 · Cited by 1,214 · cited 4×
“For example, miRNAs that decline early in adult life might be associated with, or possibly even causal in, “mid-life” crises in metabolism such as the transition to increased rates of age pigment/lipofuscin accumulation or the onset of sarcopenia [6, 14].”
BackgroundInfluentialSelf-citationSarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives
Rolland, Y., Czerwinski, S., van Kan, G. A., Morley, J. E., Cesari, M., Onder, G., Woo, J., Baumgartner, R., Pillard, F., Boirie, Y., et al. (2008) · The Journal of nutrition, health and aging · doi:10.1007/bf02982704 · Cited by 1,071 · cited 1×
“This decline is correlated with physical deterioration of the bodywall muscle cells in a manner that closely resembles human sarcopenia [6], a condition of progressive loss of muscle mass and muscle strength that begins with mid-life onset and progresses to be highly debilitating at advanced age [9, 10].”
BackgroundGarigan, D., Hsu, A.-L., Fraser, A. G., Kamath, R. S., Ahringer, J., & Kenyon, C. (2002) · Genetics · doi:10.1093/genetics/161.3.1101 · Cited by 803
MicroRNAs and Other Tiny Endogenous RNAs in C. elegans
Ambros, V., Lee, R. C., Lavanway, A., Williams, P. T., & Jewell, D. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00287-2 · Cited by 706
Canalization of development by microRNAs
Hornstein, E., & Shomron, N. (2006) · Nature Genetics · doi:10.1038/ng1803 · Cited by 578 · cited 1×
“It has been proposed that miRNAs function in biology to insure developmental robustness and maintain homeostasis [55].”
BackgroundMost Caenorhabditis elegans microRNAs Are Individually Not Essential for Development or Viability
Miska, E. A., Alvarez-Saavedra, E., Abbott, A. L., Lau, N. C., Hellman, A. B., McGonagle, S. M., Bartel, D. P., Ambros, V. R., & Horvitz, H. R. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030215 · Cited by 484 · cited 3×
“elegans model, with the plethora of molecular and genetic manipulations that can be executed, the comprehensive identification of conserved miRNAs that has been accomplished [32], the wealth of available miRNA deletion mutants [38], records of spatiotemporal expression patterns for many canonical miRNAs [37, 44-47], a…”
BackgroundCellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness
Ryall, J. G., Schertzer, J. D., & Lynch, G. S. (2008) · Biogerontology · doi:10.1007/s10522-008-9131-0 · Cited by 423 · cited 1×
“This decline is correlated with physical deterioration of the bodywall muscle cells in a manner that closely resembles human sarcopenia [6], a condition of progressive loss of muscle mass and muscle strength that begins with mid-life onset and progresses to be highly debilitating at advanced age [9, 10].”
BackgroundPuzzles, promises and a cure for ageing
Vijg, J., & Campisi, J. (2008) · Nature · doi:10.1038/nature07216 · Cited by 407 · cited 1×
“This suggests that similar processes and mechanisms modulate ageassociated decline across phyla [8].”
BackgroundGerstbrein, B., Stamatas, G., Kollias, N., & Driscoll, M. (2005) · Aging Cell · doi:10.1111/j.1474-9726.2005.00153.x · Cited by 286
Self-citationAn elt-3/elt-5/elt-6 GATA transcription circuit guides aging in C. elegans
Budovskaya, Y. V., Wu, K., Southworth, L. K., Jiang, M., Tedesco, P., Johnson, T. E., & Kim, S. K. (2008) · Cell · doi:10.1016/j.cell.2008.05.044 · Cited by 253 · cited 1×
“Recent studies that better define healthspan and aging indicators such as locomotion decline [6, 11, 26], accumulation of lipofuscin and age pigments [13, 14], pharyngeal pumping [11, 12], and even gene expression profiling [27], now make it easier to distinguish nematode progeria (accelerated aging).”
Background
Cited by
Mechanisms and Consequences of Alternative Polyadenylation
Di Giammartino, D. C., Nishida, K., & Manley, J. L. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.017 · Cited by 737
Uncoupling lifespan and healthspan in Caenorhabditis elegans longevity mutants
Bansal, A., Zhu, L. J., Yen, K., & Tissenbaum, H. A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1412192112 · Cited by 367
MicroRNAs and their roles in aging
Smith-Vikos, T., & Slack, F. J. (2012) · Journal of Cell Science · doi:10.1242/jcs.099200 · Cited by 333
Biomarkers of Aging: From Function to Molecular Biology
Wagner, K.-H., Cameron-Smith, D., Wessner, B., & Franzke, B. (2016) · Nutrients · doi:10.3390/nu8060338 · Cited by 304
MicroRNA Predictors of Longevity in Caenorhabditis elegans
Pincus, Z., Smith-Vikos, T., & Slack, F. J. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002306 · Cited by 191
Metadata
- Authors
- Ibanez-Ventoso, C., & Driscoll, M.
- Venue
- Current Genomics
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2009-05-01
- Volume
- 10
- Issue
- 3
- Pages
- 144-153
- ISSN
- 1389-2029 (ISSN-L)
- OpenAlex
- W2046533987
- Cited by
- 46
- References
- 12
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.